Company intelligence / Profile preview

GRN Capital

Cambridge, Massachusetts, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Gurnet Point Capital is a unique healthcare investment firm that provides long-term capital and operational expertise to companies across the life sciences and healthcare sectors. Founded by Ernesto Bertarelli and Christopher Viehbacher, the firm focuses on investing in businesses with high growth potential and transformative products that address significant unmet medical needs. Gurnet Point's portfolio includes a diverse range of companies involved in drug development, medical devices, and healthcare services. The firm is known for its hands-on approach, often taking controlling stakes and actively participating in the strategic direction of its portfolio companies to drive commercial success and innovation.

Industry: Investors

Partnerships

Patient Square Capital

Beyond the preview

Go deeper on GRN Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GRN Capital.

Explore the full profile